Scott W. Bloom

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients

Basem Azab, Neeraj Shah, Jared Radbel et al. · Medical Oncology · 2013 · 251 citations

Medicine, Hematology, Oncology +9

Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients

Basem Azab, Vijaya Raj Bhatt, Steven Vonfrolio et al. · The American Journal of Surgery · 2013 · 148 citations

Medicine, Oncology, Breast Oncology +10

The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer

Basem Azab, Shiksha Kedia, Neeraj Shah et al. · International Journal of Colorectal Disease · 2013 · 147 citations

Medicine, Biostatistics, Oncology +10

The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer

Basem Azab, Farhan Mohammad, Neeraj Shah et al. · Cancer Biomarkers · 2014 · 56 citations · Full text

Medicine, Hematology, Oncology +16